Hormone Replacement Therapy and Cardiovascular Disease: The Current Status of Research and Practice
CRC Press, May 15, 2001 - Medical - 200 pages
This is a high-level, clinical reference by world-class specialists on the efficacy of hormone replacement therapy for the primary prevention of cardiovascular risk in postmenopausal women. Specific chapters cover pulsed estrogen therapy with Aerodiol and cardiovascular risk assessment in postmenopausal hormone replacement therapies such as Livial (tibolone). This volume is based on the formal presentations and subsequent discussions that took place at the International Menopause Society specially convened Expert Workshop on Hormone Replacement Therapy and Cardiovascular Disease, London, UK, October 13-16, 2000.
What people are saying - Write a review
We haven't found any reviews in the usual places.
role of gender
Acute coronary syndromes in women
The estrogen receptor knockout mouse model
actions in animal models
Sex steroids and blood coagulation
the role of lecithin cholesterol acyltransferase and
Cardiovascular effects of available hormone replacement therapy
Cardiovascular risk assessment for postmenopausal hormone replacement therapies
acetate acute myocardial infarction age-associated androgenic APC resistance associated athero atherosclerosis BERKO breast cancer cardiac cardio cardiovascular disease cardiovascular risk cells Circulation Clin clinical coactivators coagulation compared coronary heart disease decrease diabetes mellitus diabetic patients diabetic women dose effects of estrogen embolism Endocrinol endothelial dysfunction endothelial function endothelium endothelium-dependent estradiol estro estrogen receptor estrogen replacement therapy Estrogen/progestin factor V Leiden factor VII female fibrinolysis Figure gene healthy hormone replacement therapy hypertension increased risk inhibition insulin ischemia ischemic LDL cholesterol levels lipids lipoprotein menopausal metabolism mg/day mice nitric oxide normal oral contraceptives placebo plasma postmeno postmenopausal postmenopausal women pregnancy prevention progesterone progestin raloxifene randomized reduced relative risk response risk factors risk of venous role SERMs serum significantly steroid stroke testosterone tibolone tion tissue transdermal treatment trial triglycerides users vascular vasodilation venous thromboembolism venous thrombosis